Optimizing osseointegration: T-PRF alone or combined with diode laser?

Osseointegration is the cornerstone of implant success, relying on a complex biological cascade of healing and bone remodeling. For the implantologist, the clinical challenge lies in the ability to accelerate this regeneration while minimizing postoperative complications. While Titanium-prepared Platelet-Rich Fibrin (T-PRF) has already proven its effectiveness, the emergence of Low-Level Laser Therapy (LLLT) as a biostimulating adjuvant raises a practical question: does the combination of both techniques surpass the exclusive use of T-PRF?

This prospective randomized controlled study was designed to settle this debate by evaluating 50 patients with unilateral posterior mandibular edentulism. The objective was to rigorously compare the biostimulating impact of T-PRF alone against a protocol combining T-PRF and diode laser. The authors tested the hypothesis that therapeutic synergy would significantly improve implant stability (measured by resonance frequency analysis - ISQ), densify peri-implant bone on CBCT, and reduce postoperative pain. The challenge is to determine whether the technological investment in laser provides a measurable clinical added value during the rehabilitation of posterior sectors.

Methodology: a randomized clinical trial on 50 patients

Osseointegration is the cornerstone of implant success. This prospective, randomized, controlled clinical trial was conducted with 50 patients presenting unilateral posterior mandibular edentulism requiring implant rehabilitation. The study aimed to compare the bio-stimulatory impact of titanium-prepared platelet-rich fibrin (T-PRF) used alone or augmented by laser.

Patients were randomly assigned to two equivalent experimental groups:

• Group A (n=25): Receipt of T-PRF alone at the implant site.
• Group B (n=25): Receipt of T-PRF combined with low-level laser therapy (LLLT) via a diode laser.

The evaluation protocol included precise measurements at defined intervals:

• Implant stability: Evaluated by resonance frequency analysis (RFA) to determine the implant stability quotient (ISQ) at the time of placement (baseline), at 3 months and at 6 months.
• Bone density: Measured by cone beam computed tomography (CBCT) to monitor peri-implant remodeling.
• Postoperative pain: Evaluated by the numerical rating scale (NRS) at several post-surgical intervals.

Data were statistically processed using SPSS software, with a significance threshold set at p < 0.05.

Osseointegration at the heart of implant success

Osseointegration is the cornerstone of implant therapy, relying on sequential bone healing and remodeling around the titanium surface. This randomized clinical study, conducted on 50 patients with unilateral posterior mandibular edentulism, evaluates whether the addition of photobiomodulation (LLLT) to T-PRF (Titanium-Platelet Rich Fibrin) optimizes these biological processes or represents a superfluous technological investment.

Implant stability and bone density: an equivalent healing profile

The analysis of stability, measured by the implant stability quotient (ISQ) via resonance frequency analysis, reveals a constant progression in both cohorts. Whether for the group receiving T-PRF alone or the group benefiting from the combined protocol (T-PRF + LLLT), the improvement in ISQ values is notable between the baseline, the 3-month follow-up, and the 6-month follow-up.

However, the inter-group comparison shows that the laser does not provide a statistically significant gain on the structural parameters:

• Stability (ISQ): No significant difference was observed between the two groups at 3 and 6 months (p > 0.05).
• Bone density (CBCT): Cone Beam imaging confirms progressive and harmonious peri-implant densification in both groups, with no superiority of the laser over bone mineralization.

Postoperative pain management: the laser advantage

It is in terms of postoperative morbidity that the difference becomes tangible for the patient. Evaluation via the Numerical Rating Scale (NRS) highlights a bio-stimulatory and analgesic effect of the diode laser during the initial inflammatory phase.

Les résultats indiquent que si le T-PRF assure une base biologique robuste pour la régénération, la LLLT agit principalement comme un adjuvant de confort, réduisant la perception douloureuse dès le deuxième jour suivant l'intervention.

Clinical analysis of results

Osseointegration is the cornerstone of implant success, relying on a complex biological cascade of healing and bone remodeling. In this randomized controlled trial conducted with 50 patients for the replacement of posterior mandibular teeth, the objective was to determine whether adding photobiomodulation (LLLT) to T-PRF (Titanium-Platelet Rich Fibrin) optimized the tissue response. The data reveal a constant and similar progression of implant stability (ISQ) and bone density (CBCT) at 3 and 6 months in both groups. Clinically, this means that T-PRF alone already provides a robust bio-stimulating environment for the mandibular bone. The addition of the diode laser does not appear to cross an additional biological threshold to accelerate mineralization or mechanical stability.

Pain reduction: the net benefit of the laser

The major point of divergence lies in the management of the patient experience. A statistically significant reduction in pain (NRS score) was observed on the second postoperative day in the T-PRF + LLLT group. This result confirms the immediate analgesic and anti-inflammatory effect of laser therapy, facilitating the critical phase of immediate recovery. However, the lack of difference in long-term stability suggests that the laser does not directly influence the kinetics of the bone-implant interface beyond what is already enabled by titanium-prepared platelet-rich fibrin.

Limits and perspectives

The study focuses exclusively on the posterior mandibular sector, an area characterized by naturally high bone density. One might question the impact of such a combination in the maxilla, where lower bone quality could potentially benefit more from combined bio-stimulation. Furthermore, although the 6-month follow-up is sufficient to validate osseointegration, it does not allow for the evaluation of long-term peri-implant soft tissue stability under the influence of the laser.

Summary of results

Osseointegration is the cornerstone of implant success. This randomized clinical study conducted on 50 patients shows that the addition of photobiomodulation (LLLT) to T-PRF significantly reduces postoperative pain on the second day (p < 0.05). However, the addition of the laser provides no additional statistical benefit compared to T-PRF alone regarding the evolution of implant stability (ISQ) or peri-implant bone density at 3 and 6 months.

In concrete terms, for the practitioner:

• Pain management: Use the diode laser as an adjuvant to improve immediate patient comfort, the analgesic effect being clinically significant at D2.
• Loading protocol: Maintain your usual protocols; the laser does not accelerate bone densification or primary/secondary stability beyond the performance of T-PRF alone.
• Resource optimization: T-PRF alone remains the sufficient biological reference for mandibular bone regeneration in this protocol, with the laser remaining a bonus focused on patient experience.

Information intended for healthcare professionals. This content may contain errors or truncated summaries. We recommend always verifying with the original source article. Delynov disclaims all responsibility regarding the use of this information. This document is not intended for patients or the general public.